A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Clinical Trial Information
Trial Contact: Manchola-Orozco, Carolina
Trial Phone: 321.841.7293
This randomized phase II/III trial studies how well standard of care therapy with stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy alone in treating patients with breast cancer that has spread to one or two locations in the body (limited metastatic) that are previously untreated.
18 Years and older with Pathologically confirmed metastatic breast cancer within 270 days prior to registration